Jupai Stock Forecast, Price & News

Wall Street analysts have given Jupai a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Jupai wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Jupai saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 25,600 shares, an increase of 197.7% from the August 15th total of 8,600 shares. Based on an average trading volume of 76,200 shares, the short-interest ratio is presently 0.3 days.
View Jupai's Short Interest.

Jupai is scheduled to release its next quarterly earnings announcement on Friday, September 24th 2021.
View our earnings forecast for Jupai.

Jupai Holdings Limited (NYSE:JP) issued its earnings results on Tuesday, May, 24th. The asset manager reported $0.16 EPS for the quarter. The asset manager earned $34.60 million during the quarter, compared to analysts' expectations of $13.90 million. Jupai had a negative net margin of 1.84% and a negative trailing twelve-month return on equity of 0.60%.
View Jupai's earnings history.

Jupai's stock was trading at $1.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, JP shares have decreased by 12.8% and is now trading at $1.02.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Jupai include Gartner (IT), Sodexo (SDXAY), R1 RCM (RCM), Terminix Global (TMX), Premier (PINC), ManTech International (MANT), Evolent Health (EVH), Franklin Covey (FC), PHI Group (PHIL), Taylor Consulting (TAYO) and Rainmaker Systems (VCTL).
View all of JP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Jupai investors own include Alibaba Group (BABA), Energy Transfer (ET), SandRidge Permian Trust (PER), Arbutus Biopharma (ABUS), Ares Capital (ARCC), AbbVie (ABBV), Applied Materials (AMAT), (BBEPQ) (BBEPQ), Dorchester Minerals (DMLP) and GAMCO Global Gold, Natural Resources & Income Trust (GGN).

(JP) raised $65 million in an initial public offering (IPO) on Thursday, July 16th 2015. The company issued 5,900,000 shares at $10.00-$12.00 per share. Credit Suisse and China Renaissance acted as the underwriters for the IPO.

Jupai trades on the New York Stock Exchange (NYSE) under the ticker symbol "JP."

Jupai's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.96%).
View institutional ownership trends for Jupai.

JP stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
View insider buying and selling activity for Jupai or or view top insider-buying stocks.

Shares of JP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JP stock can currently be purchased for approximately $1.02.

Jupai has a market capitalization of $34.39 million and generates $59.49 million in revenue each year.

Jupai employs 580 workers across the globe.

The official website for Jupai is www.jpinvestment.cn.

Jupai is headquartered at Global Creative Center T2 15/F No 166 Ming Hong Road Minhang District, Shanghai F4, 201100.

Jupai's mailing address is Global Creative Center T2 15/F No 166 Ming Hong Road Minhang District, Shanghai F4, 201100. The asset manager can be reached via phone at 86-21-5226-5925 or via email at [email protected].